CID 13143665

N-(1,2,3-trimethyl-3-pyrazolin-5-ylidene)salicylamide

Structural Information

Molecular Formula
C13H15N3O2
SMILES
CC1=CC(=NC(=O)C2=CC=CC=C2O)N(N1C)C
InChI
InChI=1S/C13H15N3O2/c1-9-8-12(16(3)15(9)2)14-13(18)10-6-4-5-7-11(10)17/h4-8,17H,1-3H3
InChIKey
UJVOYPQGFQAQDS-UHFFFAOYSA-N
Compound name
2-hydroxy-N-(1,2,5-trimethylpyrazol-3-ylidene)benzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

245.11642 Da
Monoisotopic Mass

2.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 246.12370 154.5
[M+Na]+ 268.10564 164.6
[M-H]- 244.10914 159.9
[M+NH4]+ 263.15024 171.4
[M+K]+ 284.07958 161.2
[M+H-H2O]+ 228.11368 146.5
[M+HCOO]- 290.11462 178.2
[M+CH3COO]- 304.13027 195.9
[M+Na-2H]- 266.09109 157.0
[M]+ 245.11587 156.6
[M]- 245.11697 156.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.